Anebulo Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Anebulo Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2020 to Q2 2023.
  • Anebulo Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2023 was $4.69M, a 110% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $4.69M +$2.46M +110% Jun 30, 2023 10-K 2023-09-22
Q2 2022 $2.23M +$1.43M +179% Jun 30, 2022 10-K 2023-09-22
Q2 2021 $798K +$763K +2185% Jun 30, 2021 10-K 2022-09-09
Q2 2020 $34.9K Jun 30, 2020 10-K 2021-09-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.